US Markets Market Outlook

  • Seattle Genetics CEO: Blockbuster cancer drug?

    Clay Siegall, Seattle Genetics CEO, discusses the company's center focus on treating Non-Hodgkin's lymphoma. Siegall tells CNBC's Meg Tirrell he is excited about the impact of the new drug on patients.

  • Crude crash concerns?

    Thomas Fross, Fross and Fross Wealth Management, is not concerned with the drop in crude oil prices. Dissecting market conditions, with JJ Kinahan, TD Ameritrade; Leigh Drogen, Estimize; and Rene Nourse, Ubran Wealth Management.

  • Pullback expected: Pro

    Discussing current market conditions, with Richard Lacaille, State Street Global Advisors, and Brian Lazorishak, Chase mid-cap portfolios.

  • Crude drops below $63

    For the first time since July 2009, crude prices have dropped below $63, reports CNBC's Jackie DeAngelis.

  • Street Talk: UTX, EBAY, CMG, ADT & LHO

    "Street Signs" hosts Mandy Drury and Brian Sullivan look at 5 stocks with analyst recommendations, including upgrades at United Tech and eBay.

  • Herb Greenberg: MCD just a fast food 'diner'

    CNBC contributor Herb Greenberg discusses menu problems hurting the McDonald's brand.

  • McDonald's McMess

    Following a big November sales miss for McDonald's, Peter Saleh, Telsey Advisory Group, says a turnaround will be tough.

  • Phase out gas tax; Need infrastructure bank: Pethokoukis

    Debating whether the gas tax should be raised, with CNBC contributor James Pethokoukis and Ed Rendell, former Governor of Pennsylvania.

  • Survey: 79% say gas prices higher

    How much will lower gas prices help the consumer and the economy? CNBC's Steve Liesman provides details from the All-America Economic Survey.

  • Lower oil pressures stocks: Pro

    Dissecting oil's move and its impact on certain stock sectors, with Ben Willis, Princeton Securities Group.

  • Oil's deep dive

    What's behind the continuing downward move in oil prices, with CNBC's Jackie DeAngelis.

  • A look under Tupperware's lid

    Tupperware ECO Rick Goings, discusses how the strong dollar impacts business overseas, which is 90 percent of the company's business, with CNBC's Sara Eisen.

  • Technically-driven selloff: Traders

    CNBC's Mary Thompson reports on today's downward action across major indices.

  • Better total return: Stocks or homes?

    CNBC's Diana Olick looks at whether home or stock ownership is a better way to build wealth.

  • Dow 20,000 in 2015: Pro

    What to expect from the markets in 2015, with Art Hogan, Wunderlich Securities, and Gene Peroni, Advisors Asset Management.

  • Red hot consumer stocks

    Homebuilders, media and leisure are moving the underperforming consumer discretionary sector higher, reports CNBC's Morgan Brennan.

  • Hold your horsepower: Parts makers soar

    The auto components industry group is up 14 percent this quarter, reports CNBC's Morgan Brennan.

  • Late holiday shoppers will come: Pro

    Gauging the state of holiday shoppers and mall traffic, with Liz Dunn, Talmage Advisors founder and CEO.

  • Tis' the season for stealing?

    An increase in seasonal workers may boost bottom lines for businesses but also may add risk for shoplifting. Insight, with CNBC's Kate Rogers and Scott Humphrey, Travelers Risk Control.

  • $9.5 billion blockbuster drug deal

    Following Merck's acquisition of Cubist, chairman and CEO Kenneth Frazier discusses innovation possibilities the deal presents for public health, with CNBC's Meg Tirrell.